AbbVie snagged yet another spot among April’s highest TV ad spenders, as its Vraylar jumped two spots to eighth place with a ...

Berkshire Hathaway’s Class B shares fall after Warren Buffett says he’ll be stepping down as CEO at the end of the year, and ...

This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...

Hims & Hers Health appoints former Amazon executive Nader Kabbani as its chief operating officer. The telehealth-consultation platform on Monday said Kabbani will oversee operations as the company ...

Novo Nordisk said it would sell its popular weight-loss drug Wegovy on several telehealth platforms, including Hims.

The FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the ...

Three Motley Fool contributors think they've found no-brainer healthcare stocks to buy in May. Here's why they picked Eli ...

On Friday, the company’s health services unit Evernorth unveiled new programs in a reliable growth area: helping payers ...

We recently compiled a list of the 12 Best Stocks to Buy and Hold For 10 Years. In this article, we are going to take a look ...

This report covers recent developments in the health sector, including proposed US federal budget cuts affecting scientific ...

The Trump administration proposes significant budget cuts affecting health and research sectors. Texas reports 683 measles cases amid nationwide outbreaks. Medical device demand boosts Stryker's ...